Formulary - A peer-reviewed drug management journalfor managed care and hospital decision-makers

FDA Approvals

Medication Safety & Reliability

Drug & Formulary Trends

Rx Technology Report

Formulary is a peer reviewed journal that provides timely, accurate, and practical drug-related information to assist our readers in their drug management responsibilities—evaluating drugs for the formulary and developing policies and procedures to guide the appropriate, rational, safe, and cost-effective use of drugs.

Coming in the June issue:

Cover story	Management of chronic kidney disease: An emphasis on delaying disease progression and treatment options. Chronic kidney disease remains a significant cause of morbidity and mortality.
Focus on liposomal bupivacaine injectable suspension (Exparel, Pacira Pharmaceuticals):	A long-acting local anesthetic for postsurgical analgesia
Departments:
FDA Approvals	Lucinactant (Surfaxin, Discovery Labs) is the first FDA-approved synthetic, peptide-containing surfactant for the prevention of respiratory distress syndrome. Peginesatide (Omontys, Affymax) is approved for the treatment of anemia in adult dialysis patients who have chronic kidney disease (CKD).
Drug Watch	Agents in late-stage development for the treatment of lymphoma

Subscribe Now! »

eNewsletter

Digital Edition

Magazine

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.